Caxton Associates (UK)’s Aveanna Healthcare AVAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-67,593
Closed -$552K 784
2025
Q4
$552K Buy
67,593
+12,569
+23% +$114K 0.01% 483
2025
Q3
$488K Buy
+55,024
New +$348K 0.01% 464

Other funds holding AVAH

Caxton Associates (UK)'s AVAH Position: Q1 2026 in Review

Caxton Associates (UK) sold out of Aveanna Healthcare (AVAH) in Q1 2026, closing a stake of 67,593 shares — an estimated $552K sold.

Caxton Associates (UK) first reported a position in AVAH in Q3 2025 and held it in 2 quarters. The position peaked at $552K in Q4 2025. 198 funds tracked by Wall St. Rank hold AVAH as of Q1 2026.

  • Caxton Associates (UK) reported no remaining Aveanna Healthcare position as of Q1 2026 after selling out during the quarter.
  • Caxton Associates (UK) sold 67,593 Aveanna Healthcare shares in Q1 2026, an estimated $552K.
  • Caxton Associates (UK) first reported a position in Aveanna Healthcare in Q3 2025 and held it in 2 quarters.
  • Caxton Associates (UK)'s Aveanna Healthcare position peaked at $552K in Q4 2025.
  • 198 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q1 2026.

Based on Caxton Associates (UK)'s 13F filing for Q1 2026, filed 14 May 2026.